Adicet Bio Book Value Per Share Growth & History (ACET)
Adicet Bio's book value per share was $16.61 for fiscal 2025.
View full Adicet Bio company overviewAdicet Bio annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.61 | -$19.55 | −54.07% |
| 2024 | 2024-12-31 | $36.16 | -$26.76 | −42.53% |
| 2023 | 2023-12-31 | $62.93 | -$45.97 | −42.21% |
| 2022 | 2022-12-31 | $108.89 | -$13.16 | −10.78% |
| 2021 | 2021-12-31 | $122.05 | $77.83 | +176.01% |
| 2020 | 2020-12-31 | $44.22 | $492.29 | — |
| 2019 | 2019-12-31 | -$448.07 | -$293.93 | — |
| 2018 | 2018-12-31 | -$154.15 | $460.29 | — |
| 2017 | 2017-12-31 | -$614.44 | — | — |
Adicet Bio quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.83 | -$12.80 | −49.93% |
| Q1 2026 | 2026-03-31 | $14.59 | -$16.64 | −53.27% |
| Q4 2025 | 2025-12-31 | $16.61 | -$19.55 | −54.07% |
| Q3 2025 | 2025-09-30 | $20.98 | -$20.10 | −48.93% |
| Q2 2025 | 2025-06-30 | $25.63 | -$20.02 | −43.85% |
| Q1 2025 | 2025-03-31 | $31.23 | -$19.16 | −38.03% |
| Q4 2024 | 2024-12-31 | $36.16 | -$26.76 | −42.53% |
| Q3 2024 | 2024-09-30 | $41.07 | -$31.18 | −43.16% |
| Q2 2024 | 2024-06-30 | $45.65 | -$43.16 | −48.60% |
| Q1 2024 | 2024-03-31 | $50.39 | -$48.76 | −49.18% |
| Q4 2023 | 2023-12-31 | $62.93 | -$45.97 | −42.21% |
| Q3 2023 | 2023-09-30 | $72.26 | -$46.53 | −39.17% |
| Q2 2023 | 2023-06-30 | $88.82 | -$28.43 | −24.25% |
| Q1 2023 | 2023-03-31 | $99.15 | -$25.27 | −20.31% |
| Q4 2022 | 2022-12-31 | $108.89 | -$13.16 | −10.78% |
| Q3 2022 | 2022-09-30 | $118.78 | $31.65 | +36.32% |
| Q2 2022 | 2022-06-30 | $117.25 | $2.51 | +2.19% |
| Q1 2022 | 2022-03-31 | $124.42 | $5.56 | +4.67% |
| Q4 2021 | 2021-12-31 | $122.05 | $77.83 | +176.01% |
| Q3 2021 | 2021-09-30 | $87.14 | -$8.37 | −8.76% |
| Q2 2021 | 2021-06-30 | $114.74 | $371.19 | — |
| Q1 2021 | 2021-03-31 | $118.86 | $347.32 | — |
| Q4 2020 | 2020-12-31 | $44.22 | $492.29 | — |
| Q3 2020 | 2020-09-30 | $95.50 | $287.15 | — |
| Q2 2020 | 2020-06-30 | -$256.45 | -$113.27 | — |
| Q1 2020 | 2020-03-31 | -$228.45 | -$742.51 | — |
| Q4 2019 | 2019-12-31 | -$448.07 | -$293.93 | — |
| Q3 2019 | 2019-09-30 | -$191.65 | -$694.65 | — |
| Q2 2019 | 2019-06-30 | -$143.18 | -$682.18 | — |
| Q1 2019 | 2019-03-31 | $514.06 | -$85.79 | −14.30% |
| Q4 2018 | 2018-12-31 | -$154.15 | $573.86 | — |
| Q3 2018 | 2018-09-30 | $503.00 | — | — |
| Q2 2018 | 2018-06-30 | $539.00 | — | — |
| Q1 2018 | 2018-03-31 | $599.85 | — | — |
| Q4 2017 | 2017-12-31 | -$728.01 | — | — |
Adicet Bio book value per share trends
Over the last five fiscal years, Adicet Bio's book value per share decreased from $44.22 to $16.61, a change of -$27.61. The latest reported quarter, Q2 2026, shows $12.83.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Adicet Bio source filings ↗